MECHANISM OF ACTIONS OF A MAJOR FOLATE ENZYME
MECHANISM OF ACTIONS OF A MAJOR FOLATE ENZYME
批准号:
2682266
负责人:
SERGEY A KRUPENKO
金额:
$15.2万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-08-01 至 2001-07-31
关键词:
NAD(H) phosphate active sites affinity labeling crystallization enzyme activity enzyme mechanism enzyme structure enzyme substrate epitope mapping folate high performance liquid chromatography nicotinamide adenine dinucleotide nucleotides oxidoreductase protein binding reducing agents site directed mutagenesis thiols transfection /expression vector vitamin metabolism
中文摘要
描述:10-甲酰基四氢叶酸脱氢酶(FDH)调节10-
甲酰四氢叶酸(10-甲酰四氢叶酸)和四氢叶酸(THF)池
依赖NADP的脱氢酶将10-甲酰四氢呋喃转化为四氢呋喃和二氧化碳
在NADP非依赖的水解酶反应中反应或生成苏氨酸和甲酸盐。
外佣可能通过控制10-羟色胺的水平来调节嘌呤的生物合成
甲酰四氢呋喃。申请人小组显示,NAP和IMP激活了外籍家庭佣工
这表明存在一个调控的核苷酸结合位点。外佣亦
通过将甲酸盐以二氧化碳的形式去除,在代谢甲酸盐方面起着至关重要的作用,
从而保护细胞免受甲酸盐中毒。这种酶是一种
两种无关蛋白质的自然融合,其中氨基末端
结构域具有底物结合部位和水解酶催化中心
而乙醛脱氢酶同源的催化机理
羧基末端结构域被用来作为催化中心
脱氢酶反应。因此,外佣有两个催化中心,而不是一个
底物结合部位。需要一个100个残基的中间结构域来
将两个功能域结合到中间域是
将两个功能结构域结合在一起以催化
脱氢酶反应。申请人建议中间域
是灵活的,允许构象变化,从而改变
氨基-氨基-末端构象变化的取向
从而改变氨基-氨基-羧基末端结构域的取向
调节酶活性。在体外,外佣建议2-ME直接
参与酶催化机制的具体目的包括:1)
绘制了FDH叶酸结合图,并解析了
FDH氨基末端结构域;2)研究FDH的激活机制
碱基脱氢酶的鉴定和鉴定
3)研究2-ME激活外佣的机制
并寻找可以取代2-ME的天然化合物
在细胞内;以及4)研究中间结构域的作用
FDH在酶功能中的作用。定点突变,截短的表达
FDH的形式、亲和标记、酶活性测定、结合
研究和结晶学方法将用于实现以下目标
这个项目。众所周知,叶酸缺乏和
巨幼细胞性贫血以及最近发现的与
血管疾病的风险以及叶酸在人体内的重要性
神经管缺陷的预防使这些研究变得尤为重要
切合实际。
英文摘要
DESCRIPTION:10-Formyltetrahydrofolate dehydrogenase (FDH) regulates 10-
formyltetrahydrofolate (10-formylTHF) and tetrahydrofolate (THF) pools by
converting 10-formylTHF to THF and CO2 in an NADP-dependent dehydrogenase
reaction or to THR and formate in an NADP-independent hydrolase reaction.
FDH may regulate purine biosynthesis by controlling the level of 10-
formylTHF. The applicant's group showed that NAP and IMP activate FDH
suggesting the existence of a regulatory nucleotide-binding site. FDH also
plays an essential role in metabolizing formate by removing it as CO2,
thus protecting the cell from formate intoxication. The enzyme is a
natural fusion of two unrelated proteins in which the amino-terminal
domain bears the substrate-binding site and hydrolase catalytic center
while the catalytic machinery of the aldehyde dehydrogenase homologous
carboxyl-terminal domain is used as the catalytic center in the
dehydrogenase reaction. Thus, FDH has two catalytic centers but one
substrate-binding site. A 100-residue intermediate domain is required to
bring the two functional domains together to intermediate domain is
required to bring the two functional domains together to catalyze the
dehydrogenase reaction. The applicant suggest that the intermediate domain
of FDH is flexible and allows conformational changes which alter the
orientation of the amino- an carboxyl-terminal conformational changes
which alter the orientation of the amino-an carboxyl-terminal domains thus
regulating enzyme activity. In vitro, FDH proposes that 2-ME be directly
involved in the mechanism of enzyme catalysis Specific aims include: 1) to
map the FDH folate binding, and to resolve the crystal structure of the
amino-terminal domain of FDH; 2) to study the mechanism of activation of
FDH by nucleotide including identification and characterization of the
regulatory site; 3) to study the mechanism of activation of FDH by 2-ME
and to search for naturally occurring compounds which can replace 2-ME
inside the cell; and 4) to study the role of the intermediate domain of
FDH in enzyme function. Site-directed mutagenesis, expression of truncated
forms of FDH, affinity labeling, assay of enzyme activity, binding
studies, and crystallographic methods will be used to achieve the goals of
the project. The well-known relationship between folate deficiency and
megaloblastic anemia a well as the recently discovered association with
the risk of vascular disease together with the importance of folate in
prevention of neural-tube defects make these studies particularly
relevant.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanistic and metabolomic underpinnings of ALDH1L1 polymorphisms in the regulation of glycine metabolism
-
批准号:10297073
-
项目类别:
-
资助金额:$65.7万
-
财政年份:2021
-
负责人:SERGEY A KRUPENKO
-
依托单位:
Mechanistic and metabolomic underpinnings of ALDH1L1 polymorphisms in the regulation of glycine metabolism
-
批准号:10870688
-
项目类别:
-
资助金额:$24.57万
-
财政年份:2021
-
负责人:SERGEY A KRUPENKO
-
依托单位:
Mechanistic and metabolomic underpinnings of ALDH1L1 polymorphisms in the regulation of glycine metabolism
-
批准号:10663183
-
项目类别:
-
资助金额:$62.59万
-
财政年份:2021
-
负责人:SERGEY A KRUPENKO
-
依托单位:
Mechanistic and metabolomic underpinnings of ALDH1L1 polymorphisms in the regulation of glycine metabolism
-
批准号:10453683
-
项目类别:
-
资助金额:$63.52万
-
财政年份:2021
-
负责人:SERGEY A KRUPENKO
-
依托单位:
Regulation of mitochondrial function by folate enzyme ALDH1L2 in health and disease
-
批准号:10597021
-
项目类别:
-
资助金额:$47.58万
-
财政年份:2019
-
负责人:SERGEY A KRUPENKO
-
依托单位:
Regulation of mitochondrial function by folate enzyme ALDH1L2 in health and disease
-
批准号:10117233
-
项目类别:
-
资助金额:$47.58万
-
财政年份:2019
-
负责人:SERGEY A KRUPENKO
-
依托单位:
Regulation of mitochondrial function by folate enzyme ALDH1L2 in health and disease
-
批准号:10372093
-
项目类别:
-
资助金额:$47.58万
-
财政年份:2019
-
负责人:SERGEY A KRUPENKO
-
依托单位:
FDH: A Novel Determinant of Tumor Suppression
-
批准号:8895055
-
项目类别:
-
资助金额:$24.09万
-
财政年份:2014
-
负责人:SERGEY A KRUPENKO
-
依托单位:
Mechanism of action of a major folate enzyme
-
批准号:8013378
-
项目类别:
-
资助金额:$9.65万
-
财政年份:2010
-
负责人:SERGEY A KRUPENKO
-
依托单位:
FDH: A Novel Determinant of Tumor Suppression
-
批准号:7017706
-
项目类别:
-
资助金额:$25.34万
-
财政年份:2005
-
负责人:SERGEY A KRUPENKO
-
依托单位:
FDH: A Novel Determinant of Tumor Suppression
-
批准号:7558315
-
项目类别:
-
资助金额:$24.61万
-
财政年份:2005
-
负责人:SERGEY A KRUPENKO
-
依托单位:
FDH: A Novel Determinant of Tumor Suppression
-
批准号:8634029
-
项目类别:
-
资助金额:$0.4万
-
财政年份:2005
-
负责人:SERGEY A KRUPENKO
-
依托单位:
FDH: A Novel Determinant of Tumor Suppression
-
批准号:8075580
-
项目类别:
-
资助金额:$24.84万
-
财政年份:2005
-
负责人:SERGEY A KRUPENKO
-
依托单位:
FDH: A Novel Determinant of Tumor Suppression
-
批准号:8240898
-
项目类别:
-
资助金额:$24.84万
-
财政年份:2005
-
负责人:SERGEY A KRUPENKO
-
依托单位:
FDH: A Novel Determinant of Tumor Suppression
-
批准号:7184330
-
项目类别:
-
资助金额:$24.61万
-
财政年份:2005
-
负责人:SERGEY A KRUPENKO
-
依托单位:
FDH: A Novel Determinant of Tumor Suppression
-
批准号:6868586
-
项目类别:
-
资助金额:$25.95万
-
财政年份:2005
-
负责人:SERGEY A KRUPENKO
-
依托单位:
FDH: A Novel Determinant of Tumor Suppression
-
批准号:7918678
-
项目类别:
-
资助金额:$25.61万
-
财政年份:2005
-
负责人:SERGEY A KRUPENKO
-
依托单位:
FDH: A Novel Determinant of Tumor Suppression
-
批准号:8444313
-
项目类别:
-
资助金额:$23.35万
-
财政年份:2005
-
负责人:SERGEY A KRUPENKO
-
依托单位:
FDH: A Novel Determinant of Tumor Suppression
-
批准号:7356442
-
项目类别:
-
资助金额:$24.61万
-
财政年份:2005
-
负责人:SERGEY A KRUPENKO
-
依托单位:
MECHANISM OF ACTION OF A MAJOR FOLATE ENZYME
-
批准号:6785408
-
项目类别:
-
资助金额:$21.81万
-
财政年份:1998
-
负责人:SERGEY A KRUPENKO
-
依托单位:
海外基金